Zitha Redempta Isingizwe

Statistics

Publications

Citations

164

H-Index

Active since

2017

Affiliations

University of Oklahoma Health Sciences Center(Current)

Oklahoma Medical Research Foundation

Zitha Redempta Isingizwe is an author at University of Oklahoma Health Sciences Center specializing in pharmacology, medicine, and cancer pharmacology.

ORCID

Publications per year

2017–2020

Publications

Potential and mechanism of mebendazole for treatment and maintenance of ovarian cancer

Suganthapriya Elayapillai, Satishkumar Ramraj, Doris M. Benbrook et al. · Gynecologic Oncology · 2020 · 50 citations · Full text

Medicine, Oncology, Pharmacology +11

Novel ovarian cancer maintenance therapy targeted at mortalin and mutant p53

Satish Kumar Ramraj, Sugantha Priya Elayapillai, Richard Pelikan et al. · International Journal of Cancer · 2019 · 41 citations · Full text

Medicine, Oncology, Pharmacology +17

12-HETrE inhibits platelet reactivity and thrombosis in part through the prostacyclin receptor

Benjamin E. Tourdot, Reheman Adili, Zitha Redempta Isingizwe et al. · Blood Advances · 2017 · 36 citations · Full text

Medicine, Hematology, Pharmacology +15

Studies of drug interactions with alpha 1 -acid glycoprotein by using on-line immunoextraction and high-performance affinity chromatography

Cong Bi, Ryan Matsuda, Chenhua Zhang et al. · Journal of Chromatography A · 2017 · 23 citations

Pharmacy, Pharmaceutics, Pharmacology +9

Complementary Targeting of Rb Phosphorylation and Growth in Cervical Cancer Cell Cultures and a Xenograft Mouse Model by SHetA2 and Palbociclib

Amy L. Kennedy, Rajani Rai, Zitha Redempta Isingizwe et al. · Cancers · 2020 · 14 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 5